Page last updated: 2024-10-31

acecainide and Diabetic Glomerulosclerosis

acecainide has been researched along with Diabetic Glomerulosclerosis in 1 studies

Acecainide: A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
N-acetylprocainamide : A benzamide obtained via formal condensation of 4-acetamidobenzoic acid and 2-(diethylamino)ethylamine.

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Low, CL	1
Phelps, KR	1
Bailie, GR	1

Other Studies

1 other study available for acecainide and Diabetic Glomerulosclerosis

Article	Year
Relative efficacy of haemoperfusion, haemodialysis and CAPD in the removal of procainamide and NAPA in a patient with severe procainamide toxicity. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:5 Topics: Acecainide; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Diabetic Nephropathies; Hemoperfusion	1996

Article

Year

Relative efficacy of haemoperfusion, haemodialysis and CAPD in the removal of procainamide and NAPA in a patient with severe procainamide toxicity.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:5

Topics: Acecainide; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Diabetic Nephropathies; Hemoperfusion

1996